RxDoctor Payments Data

Ma Rosa Brown

Nurse Practitioner · Rockville, MDNPI 1548012958

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,860, more than ten times the $27 reported in 2023. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,087in general payments, 2019–2025

Across 123 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$508
  • Novartis$404
  • Incyte Corporation$217
  • AbbVie$201
  • Daiichi Sankyo Inc.$151
  • Beone Medicines USA, Inc.$110
  • plus $1K from 35 others

What the payments were for

  • Food & beverage$2,90994%
  • Education$1786%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,087 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.

See all nurse practitioner providers in Maryland →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$10,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$83$10,26912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,562 nurse practitioner providers in Maryland.

Other nurse practitioner in Rockville

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →